Cargando…

Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study

BACKGROUND: Placebo-treatment acceptability is debated among ethicists, mostly due to conflict between respect-to-autonomy and beneficence principles. It is not clear how lay people balance these and other ethical principles. METHODS: One hundred and eighty-seven respondents rank-ordered 42 opinion...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammami, Muhammad M, Hammami, Safa, Aboushaar, Reem, Aljomah, Ahmed S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776293/
https://www.ncbi.nlm.nih.gov/pubmed/31631979
http://dx.doi.org/10.2147/PPA.S216565
_version_ 1783456394333126656
author Hammami, Muhammad M
Hammami, Safa
Aboushaar, Reem
Aljomah, Ahmed S
author_facet Hammami, Muhammad M
Hammami, Safa
Aboushaar, Reem
Aljomah, Ahmed S
author_sort Hammami, Muhammad M
collection PubMed
description BACKGROUND: Placebo-treatment acceptability is debated among ethicists, mostly due to conflict between respect-to-autonomy and beneficence principles. It is not clear how lay people balance these and other ethical principles. METHODS: One hundred and eighty-seven respondents rank-ordered 42 opinion statements covering various ethical aspects of placebo-treatment, according to a 9-category symmetrical distribution. We analyzed statements’ scores using averaging-analysis and by-person factor analysis (Q-methodology). RESULTS: Respondents’ mean (SD) age was 34.6 (10.6) years, 54% were women, 40% healthcare-related, 68% Muslims (31% Christians), and 39% received general education in Saudi Arabia (24% in the Philippines). On averaging-analysis, the most-agreeable statements were “Acceptable if benefit to patient large” and “Acceptable with physician intent to benefit patient”. The most-disagreeable statements were “Acceptable with physician self-benefit intent” and “Acceptable with large harm to other patients”. Muslims gave a higher rank to “Giving no description is acceptable”, “Acceptable with small benefit to patient”, and “Acceptable with physician intent to benefit patient” and a lower rank to “Acceptable to describe as inactive drug”, “Acceptable with physician intent to please patient caring relative”, and “Acceptable with moderate harm to other patients” (p<0.01). Q-methodology detected several ethical attitude models that were mostly multi-principled and consequentialism-dominated. The majority of Christian and Philippines-educated women loaded on a “relatively family and deception-concerned” model, whereas the majority of Muslim and Saudi Arabia-educated women loaded on a “relatively common-good-concerned” model. The majority of Christian and healthcare men loaded on a “relatively deception-concerned” model, whereas the majority of Muslim and non-healthcare men loaded on a “relatively motives-concerned” model. Of nine intent-related statements, ≥2 received extreme rank on averaging-analysis and in 100% of women and men models. CONCLUSION: 1) On averaging-analysis, patient’s beneficence (consequentialism) followed by physician’s intent (virtue ethics) were more important than deception (respect-to-autonomy). 2) Q-methodology identified several ethical attitude models that were mostly multi-principled and associated with respondents’ demographics.
format Online
Article
Text
id pubmed-6776293
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67762932019-10-18 Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study Hammami, Muhammad M Hammami, Safa Aboushaar, Reem Aljomah, Ahmed S Patient Prefer Adherence Original Research BACKGROUND: Placebo-treatment acceptability is debated among ethicists, mostly due to conflict between respect-to-autonomy and beneficence principles. It is not clear how lay people balance these and other ethical principles. METHODS: One hundred and eighty-seven respondents rank-ordered 42 opinion statements covering various ethical aspects of placebo-treatment, according to a 9-category symmetrical distribution. We analyzed statements’ scores using averaging-analysis and by-person factor analysis (Q-methodology). RESULTS: Respondents’ mean (SD) age was 34.6 (10.6) years, 54% were women, 40% healthcare-related, 68% Muslims (31% Christians), and 39% received general education in Saudi Arabia (24% in the Philippines). On averaging-analysis, the most-agreeable statements were “Acceptable if benefit to patient large” and “Acceptable with physician intent to benefit patient”. The most-disagreeable statements were “Acceptable with physician self-benefit intent” and “Acceptable with large harm to other patients”. Muslims gave a higher rank to “Giving no description is acceptable”, “Acceptable with small benefit to patient”, and “Acceptable with physician intent to benefit patient” and a lower rank to “Acceptable to describe as inactive drug”, “Acceptable with physician intent to please patient caring relative”, and “Acceptable with moderate harm to other patients” (p<0.01). Q-methodology detected several ethical attitude models that were mostly multi-principled and consequentialism-dominated. The majority of Christian and Philippines-educated women loaded on a “relatively family and deception-concerned” model, whereas the majority of Muslim and Saudi Arabia-educated women loaded on a “relatively common-good-concerned” model. The majority of Christian and healthcare men loaded on a “relatively deception-concerned” model, whereas the majority of Muslim and non-healthcare men loaded on a “relatively motives-concerned” model. Of nine intent-related statements, ≥2 received extreme rank on averaging-analysis and in 100% of women and men models. CONCLUSION: 1) On averaging-analysis, patient’s beneficence (consequentialism) followed by physician’s intent (virtue ethics) were more important than deception (respect-to-autonomy). 2) Q-methodology identified several ethical attitude models that were mostly multi-principled and associated with respondents’ demographics. Dove 2019-09-27 /pmc/articles/PMC6776293/ /pubmed/31631979 http://dx.doi.org/10.2147/PPA.S216565 Text en © 2019 Hammami et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hammami, Muhammad M
Hammami, Safa
Aboushaar, Reem
Aljomah, Ahmed S
Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title_full Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title_fullStr Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title_full_unstemmed Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title_short Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study
title_sort lay people’s ethical attitudes to placebo treatment: a q-methodology study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776293/
https://www.ncbi.nlm.nih.gov/pubmed/31631979
http://dx.doi.org/10.2147/PPA.S216565
work_keys_str_mv AT hammamimuhammadm laypeoplesethicalattitudestoplacebotreatmentaqmethodologystudy
AT hammamisafa laypeoplesethicalattitudestoplacebotreatmentaqmethodologystudy
AT aboushaarreem laypeoplesethicalattitudestoplacebotreatmentaqmethodologystudy
AT aljomahahmeds laypeoplesethicalattitudestoplacebotreatmentaqmethodologystudy